Response to: 'Correspondence on ' Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al

Ann Rheum Dis. 2022 Aug 11;81(9):e164. doi: 10.1136/annrheumdis-2020-218680.
No abstract available

Keywords: arthritis; cardiovascular diseases; hydroxychloroquine; rheumatoid.